Class II, Major Histocompatibility Complex, Transactivator (CIITA) (N-Term) Peptide
CIITA
Reactivity: Human
BP
Sodium azide
-
- Target See all CIITA products
- CIITA (Class II, Major Histocompatibility Complex, Transactivator (CIITA))
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
16 amino acids near the amino terminus of human CIITA.
Human
-
-
- Application Notes
- CIITA peptide is used for blocking the activity of CIITA.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- CIITA (Class II, Major Histocompatibility Complex, Transactivator (CIITA))
- Synonyms
- CIITA Peptide, C2ta Peptide, EG669998 Peptide, Gm9475 Peptide, C2TA Peptide, CIITAIV Peptide, MHC2TA Peptide, NLRA Peptide, Mhc2ta Peptide, class II, major histocompatibility complex, transactivator Peptide, class II major histocompatibility complex transactivator Peptide, MHC class II transactivator Peptide, class II transactivator Peptide, CIITA Peptide, LOC710761 Peptide, ciita Peptide, LOC100443575 Peptide, Ciita Peptide, LOC100736732 Peptide
-
You are here:
